Intravenous lipid emulsions in the critically ill: An update

Current Opinion in Critical Care

Volumn 22, Issue 4, 2016, Pages 308-315

  Manzanares, William ^a   Langlois, Pascal L ^b   Hardy, Gil ^c  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c Ipanema Research Trust   (New Zealand)

Author keywords

alternative lipid emulsions; critically ill; fish oil; meta analyses; olive oil; parenteral nutrition; soybean oil

Indexed keywords

CLINOLEIC; DOCOSAHEXAENOIC ACID; FISH OIL; INTRALIPID; INTRAVENOUS LIPID EMULSION; LIPID EMULSION; LIPOFUNDIN; LIPOVENOES; OLEIC ACID; OLIVE OIL; OMEGA 6 FATTY ACID; OMEGAVEN; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; SOYBEAN OIL EMULSION; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; SOYBEAN OIL;

ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LIPID COMPOSITION; LIVER DISEASE; NONHUMAN; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; REVIEW; CHEMISTRY; CRITICAL ILLNESS; DRUG EFFECTS; IMMUNE SYSTEM; INFLAMMATION; PROCEDURES;

ANTI-INFLAMMATORY AGENTS; CRITICAL CARE; CRITICAL ILLNESS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; OLIVE OIL; PARENTERAL NUTRITION; SOYBEAN OIL;

EID: 84973139097     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000314     Document Type: Review

References (43)

1. McClave S, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in theadult critically ill patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and EnteralNutrition (A.S.P.E.N.). JPENJ ParenterEnteralNutr2016; 40:159-211.
2. Hecker M, Mayer K. Intravenous lipids in adult intensive care unit patients. World Rev Nutr Diet 2015; 112:120-126.
3. Teitelbaum DH, Guenter P, Griebel D, et al. Proceedings from FDA/A.S.P.E.N. Public workshop: clinical trial design for intravenous fat emulsion products, October 29, 2013. JPEN J Parenter Enteral Nutr 2015; 39:768-786.
4. Boisramé-Helms J, Toti F, Hasselmann M, et al. Lipid emulsions for parenteral nutrition in critical illness. Progress Lipid Res 2015; 60:1-6.
5. Calder PC. Lipids for intravenous nutrition in hospitalized adult patients: a multiple choice of options. Proc Nutr Soc 2013; 72:263-276.
6. Edmunds CE, Brody RA, Parrott JS, et al. The effects of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med 2014; 42:1168-1177.
7. Calder PC. Fishing for improved outcomes in the critically ill. Crit Care Med 2014; 42:1306-1307.
8. Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015; 1851:469-484.
9. Heller AR. Intravenous fish oil in adult intensive care unit patients. World Rev Nutr Diet 2015; 112:127-140.
10. Martindale RG, Warren MM, McClave SA. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils? Curr Opin Clin Nutr Metab Care 2016; 19:151-154.
11. Terashima M, Aoyama-Ishikawa M, Ueda T, et al. The effects of n-3 polyunsaturated fatty acid-rich total parenteral nutrition on neutrophil apoptosis in a rat endotoxemia. J Clin Biochem Nutr 2013; 52:154-159.
12. Hecker M, Ott J, Sondermann C, et al. Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome. Crit Care 2014; 18:R85.
13. Manzanares W, Langlois PL, Dhaliwal R, et al. Intravenous fish oil lipid emulsion in critically ill patients: an updated systematic review and metaanalysis. Crit Care 2015; 19:167.
14. Grecu I, Mirea L, Grintescu I. Parenteral fish oil supplementation in patients with abdominal sepsis [abstract]. Clin Nutr 2003; 22 (suppl 1):S23.
15. Friesecke S, Lotze C, Kohler J, et al. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomized controlled trial. Intensive Care Med 2008; 34:1411-1420.
16. Wang X, Li W, Zhang F, et al. Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial. Inflammation 2009; 32:304-309.
17. Barbosa VM, Miles EA, Calhau C, et al. Effects of fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010; 14:R5.
18. Gupta A, Govil D, Bhatnagar S, et al. Efficacy and safety of parenteral omega-3 fatty acids in ventilated patients with acute lung injury. Indian J Crit Care Med 2011; 15:108-113.
19. Khor BS, Liaw SJ, Shih HC, et al. Randomized, double blind, placebocontrolled trial of fish-oil based lipid emulsion infusion for treatment of critically ill patients with severe sepsis. Asian J Surg 2011; 34:1-10.
20. Grau-Carmona T, Bonet-Saris A, Garća-de-Lorenzo A, et al. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU Lipids Study. Crit Care Med 2015; 43:31-39.
21. Burkhart CS, Dell-Kuster S, Siegemund M, et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients. Acta Anesthesiol Scand 2014; 58:689-700.
22. Gultekin G, Sahin H, Inanc N, et al. Impact of Omega-3 and Omega-9 fatty acids enriched total parenteral nutrition on blood chemistry and inflammatory markers in septic patients. Pak J Med Sci 2014; 30:299-304.
23. Hall TC, Bilku DK, Al-Leswas D, et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: a pilot study. JPEN J Parenter Enteral Nutr 2015; 39:301-312.
24. Berger MM, Delodder F, Liaudet L, et al. Three short perioperative infusions of n-3PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr 2013; 97:246-254.
25. Lomivorotov VV, Efremov SM, Pokushalov EA, et al. Randomized trial of fish oil infusion to prevent atrial fibrillation after cardiac surgery: data from an implantable continuous cardiac monitor. J Cardiothorac Vasc Anesth 2014; 28:1278-1284.
26. Kolesnikov VN, Boeva OI, Yagoda AV, et al. Medical News of North Caucasus 2015; 10:121-127.
27. Langlois PL, Manzanares W. Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis. Crit Care 2016; 20 (Suppl 2):119.
28. Manzanares W, Langlois PL. Fish oil containing lipid emulsions in critically ill patients: critical analysis and future perspectives. Med Intensiva 2016; 40:39-45.
29. Fish OIL Optimal dosE Determination Study (FOILED) ClinicalTrials.gov Identifier: NCT01146821. [Accessed 19 February 2016].
30. Jia ZY, Yang J, Xia Y, et al. Safety and efficacy of an olive oil-based triplechamber bag for parenteral nutrition: a prospective, randomized, multicenter clinical trial in China. J Nutr 2015; 14:119.
31. Won Park H, Mi Lee N, Kim JH, et al. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr 2015; 145:227-283.
32. Burrin DG, Ng K, Stoll B, et al. Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. Adv Nutr 2014; 5:82-91.
33. Zugasti Murillo A, Petrina Já uregui E, Elizondo Armendá riz J. Parenteral nutrition-associated liver disease and lipid emulsions. Endocrinol Nutr 2015; 62:285-289.
34. Wanten GJA. Parenteral lipid tolerance and adverse effects: fat chance for trouble? JPEN J Parenter Enteral Nutr 2015; 39:33S-38S.
35. Badia-Tahull MB, Llop-Talaveron J, Leiva-Badosa E. Impact of intravenous lipid emulsions on liver function tests: contribution of parenteral fish oil. Nutrition 2015; 31:1109-1116.
36. Wang Y, Zhou KJ, Tang KY, et al. Effect of an olive oil-based lipid emulsion compared with a soybean oil-based lipid emulsion on liver chemistry and bile acid composition in preterm infants receiving parenteral nutrition: a doubleblind, randomized trial. JPEN J Parenter Enteral Nutr 2015. [Epub ahead of print]
37. Zaloga GP. Phytosterols, lipid administration, and liver disease during parenteral nutrition. JPEN J Parenter Enteral Nutr 2015; 39 (suppl.1):39S-60S.
38. Manzanares W, Dhaliwal R, Jurewitsch B, et al. Alternative lipid emulsions in the critically ill: a systematic review of the evidence. Intensive Care Med 2013; 39:1683-1694.
39. Pradelli L, Mayer K, Muscaritoli M, et al. n-3 fatty acid enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care 2012; 16:R184.
40. Palmer AJ, Ho CKM, Ajibola O, Avenell A. The role of n-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med 2013; 41:307-316.
41. Manzanares W, Dhaliwal R, Jurewitsch B, et al. Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 2014; 38:20-28.
42. Manzanares W, Langlois PL, Lemieux M, et al. Fish oil-containing emulsions: when fat seems to improve clinical outcomes in the critically ill. JPEN J Parenter Enteral Nutr 2016; 40:305-307.
43. Canadian Clinical Practice Guidelines 2015. Section 9.2: composition of parenteral nutrition: type of lipids. www.criticalcarenutrition.com. [Accessed 22 February 2016].